Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: 4FMFES-PET Imaging of Endometrial and Ovarian Cancers [Phase 1, Phase 2]
Clinical trial update announcing the completion of a Phase 1/Phase 2 study evaluating 4FMFES-PET imaging for Endometrial cancer and Ovarian …
-
FDA approval · 2024-05-10FDA Approved: CISPLATIN — Original Application (Apotex Corp.)
FDA approved the original application for cisplatin from Apotex Corp., enabling the generic version to be marketed in the United States.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial) [Phase 2]
Phase 2 STROBE trial evaluating HRD-driven benefit from combining olaparib with bevacizumab in ovarian cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
This ongoing clinical trial investigates the use of circulating tumor DNA as a biomarker to improve the diagnosis of ovarian cancer and is c…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Improved Diagnosis of Ovarian Cancer
A clinical trial update from the University of Aarhus indicates a study aimed at improving the diagnosis of ovarian cancer is currently recr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer [NA]
The LCC-CARIS-01 trial focusing on molecular profiling in gynecologic cancers has completed. The study included epithelial ovarian cancer, p…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer [NA]
This clinical trial update discusses the timing of surgery after neoadjuvant chemotherapy for advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: (GI-RADS) in Preoperative Evaluation of Adnexal Masses
A completed clinical trial evaluating GI-RADS for preoperative evaluation of adnexal masses in ovarian cancer, reporting diagnostic performa…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib [Phase 3]
Phase 3 rollover study CATCH-R provides continued access to rucaparib for eligible patients with metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen [Phase 2]
Phase 2 clinical trial evaluating Efbemalenograstim alfa injection in patients with ovarian or cervical cancer receiving chemotherapy. The s…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer [NA]
This document describes a clinical trial evaluating the Fasting Mimicking Diet in combination with chemotherapy for advanced ovarian cancer;…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating 89Zr-MMOT PET imaging in pancreatic and ovarian cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: A Study of DeTIL-0255 in Adults With Advanced Malignancies [Phase 1]
Phase 1 study of DeTIL-0255 in adults with advanced cancers (ovarian, endometrial, and cervical cancer) sponsored by Nurix Therapeutics has …
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: DOvEE - Diagnosing Ovarian & Endometrial Cancer Early
A clinical trial update for DOvEE (Diagnosing Ovarian & Endometrial Cancer Early) currently RECRUITING.
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating intraperitoneal METR-NK cells as neoadjuvant therapy for advanced epithelial ovarian cancer is currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer
This clinical trial update reports that the study evaluating systematic lymphadenectomy during interval debulking surgery for advanced epith…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer [Phase 1]
The Phase 1 study of KHK2866, an HB-EGF–targeting antibody, in advanced solid tumors and ovarian cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-04-25Clinical Trial Update: Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer [Phase 1]
Phase 1 clinical trial investigating neuroinflammation and age-related brain pathology as potential mechanisms of cognitive impairment in ov…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors [Phase 1]
This is a Phase 1 clinical trial studying Anti-CD70 UCAR-T for relapsed or refractory solid tumors, with not yet recruiting status.
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in participants with recurrent ovarian, fallopian tube, or primary peritoneal carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-07263689 in selected advanced solid tumors was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
Phase Ib/II clinical study evaluating HRS-1167 in combination with bevacizumab for recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy [Phase 1]
Phase 1 trial evaluating magrolimab (Hu5F9-G4) with avelumab in solid tumors and checkpoint-inhibitor-naive ovarian cancer patients who prog…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) [Phase 3]
Phase 3 clinical trial evaluating tumor treating fields with weekly paclitaxel for recurrent ovarian cancer has completed.
-
FDA approval · 2024-03-22FDA Approved: ELAHERE — Supplemental Application (ImmunoGen, Inc.)
FDA approves a supplemental application for ELAHERE (mirvetuximab soravtansine) from ImmunoGen, Inc. The approval updates the labeling to re…